| 1 |
Ferenci P, Fried M, Labrecque D, et al． Hepatocellular carcinoma ( HCC) : a global perspective[J]．J Clin Gastroenterol，2010，44(4):239-245．
|
| 2 |
刘会春.中国原发性肝癌治疗指南解读[J]. 肝胆外科杂志,2013,21(1):12-15.
|
| 3 |
Sun WB. How is radiofrequency ablation going in treating hepatocellular carcinoma in China[J]? Austral-Asian Journal of Cancer, 2008,7(4):221-224.
|
| 4 |
Lau WY, Lai EC. The current role of radiofrequency ablation in the management of hepatocellular carcinoma: a systematic review[J]. Ann Surg, 2009, 249(1):20-25.
|
| 5 |
Takayasu K, Arii S, Ikai I, et al. Prospective cohort study of transarterial chemoembolization for unresectable hepatocellular carcinoma in 8,510 patients[J]. Gastroenterology, 2006,131(2):461-469.
|
| 6 |
Jeon SH, Park KS, Kim YH, et al. Incidence and risk factors of acute hepatic failure after transcatheter arterial chemo-embolization for hepatocellular carcinoma[J]. Korean J Gastroenterol, 2007,50(3):176-182.
|
| 7 |
Lewis AL, Taylor RR, Hall B, et al. Pharmacokinetic and safety study of doxorubicin-eluting beads in a porcine model of hepatic arterial embolisation[J]. J Vasc Interv Radiol, 2006,17(8):1335-1343.
|
| 8 |
Hong K, Khwaja A, Liapi E, et al. New intra-arterial drug delivery system for the treatment of liver cancer: preclinical assessment in a rabbit model of liver cancer[J]. Clin Cancer Res, 2006,12(8):2563-2567.
|
| 9 |
Varela M, Real MI, Burrel M, et al. Chemoembolisation of hepatocellular carcinoma with drug eluting beads: efficacy and doxorubicin pharmacokinetics[J]. J Hepatol, 2007,46(3):474-481.
|
| 10 |
Poon RT, Tso WK, Pang RW, et al. A phase Ⅰ/Ⅱ trial of chemoembolisation for hepatocellular carcinoma using a novel intra-arterial drug-eluting bead[J]. Clin Gastroenterol Hepatol, 2007,5(9):1100-1108.
|
| 11 |
Kettenbach J, Stadler A, Katzler IV, et al. Drug-loaded microspheres for the treatment of liver cancer: review of current results[J]. Cardiovasc Interv Radiol, 2008,31(3):468-476.
|
| 12 |
Malagari K, Chatzimichael K, Alexopoülou E, et al. Transarterial chemoembolisation of unresectable hepatocellular carcinoma with drug eluting beads: results of an open-label study of 62 patients[J]. Cardiovasc Interv Radiol, 2008,31(2):269-280.
|
| 13 |
Reyes DK, Vossen JA, Kamel IR, et al. Single-center phase Ⅱ trial of transarterial chemo-embolization with drug- eluting beads for patients with unresectable hepatocellular carcinoma: initial experience in the United States[J]. Cancer J, 2009,15(6):526-532.
|
| 14 |
Loffroy R, Guiu B, Cercueil JP, et al．Endovascular therapeutic embolisation: An overview of occluding agents and their effects on embolised tissues[J]．Curr Vasc Pharmacol，2009,7(2):250-263．
|
| 15 |
Laurent A．Microspheres and nonspherical particles for embolization[J]．Tech Vasc Interv Radiol, 2007,10(4):248-256．
|
| 16 |
Song MJ, Park CH, Kim JD, et al. Drug-eluting bead loaded with doxorubicin versus conventional Lipiodol-based transarterial chemoembolization in the treatment of hepatocellular carcinoma: a case–control study of Asian patients[J]. Eur J Gastroenterol Hepatol, 2011,23(6):521-527.
|
| 17 |
Dhanasekaran R, Kooby DA, Staley CA, et al. Comparison of conventional transarterial chemoembolization (TACE) and chemoembolization with doxorubicin drug eluting beads (DEB) for unresectable hepatocelluar carcinoma (HCC)[J]. J Surg Oncol, 2010,101(6):476-480.
|
| 18 |
van Malenstein H, Maleux G, Vandecaveye V, et al. A randomized phase Ⅱ study of drug-eluting beads versus transarterial chemoembolization for unresectable hepatocellular carcinoma[J]. Onkologie, 2011,34(7):368-376 .
|
| 19 |
杨奎，尹君，雪广.不同介入模式治疗肝癌的比较研究[J]. 临床放射学杂志，2006，25(7):658-661.
|
| 20 |
Lammer J, Malagari K, Vogl T, et al. Prospective Randomized Study of Doxorubicin-Eluting-Bead Embolization in the Treatment of Hepatocellular Carcinoma: Results of the PRECISION V Study[J]. Cardiovasc Intervent Radiol,2010,33(1):41–52 .
|
| 21 |
Scartozzi M, Baroni GS, Faloppi L, et al. Transarterial Chemo-embolization (TACE), with either ipiodol(traditional TACE) or drug-eluting microspheres (precision TACE, pTACE) in the treatment of hepatocellular carcinoma: efficacy and safety results from a large mono-institutional analysis[J]. J Exp Clin Cancer Res, 2010,29:164.
|
| 22 |
Salem R, Lewandowski RJ, Mulcahy MF, et al. Radioembolization for hepatocellular carcinoma using Yttrium-90 microspheres: A comprehensive report of long-term outcomes[J].Gastroenterology. 2010,138(1):52-64.
|
| 23 |
Moreno-Luna LE, Yang JD, Sanchez W, et al. Efficacy and safety of transarterial radioembolization versus chemoembolization in patients with hepatocellular carcinoma[J]. Cardiovasc Intervent Radiol, 2013,36(3):714-723.
|
| 24 |
Kooby DA, Egnatashvili V, Srinivasan S, et al. Comparison of Yttrium-90 radioembolization and transcatheter arterial chemoembolization for the treatment of unresectable hepatocellular carcinoma[J]. J Vasc Interv Radiol, 2010,21(2):224-230.
|
| 25 |
Sato K, Lewandowski RJ, Bui JT, et al. Treatment of unresectable primary and metastatic liver cancer with Yttrium-90 microspheres (TheraSphere):Assessment of hepatic arterial embolization[J].Cardiovasc Intervent Radiol, 2006,29(4):522-529.
|
| 26 |
邹子扬，赵春梅，李双成，等.海藻酸钠微球血管栓塞剂栓塞治疗原发性肝癌临床研究[J].临床荟萃，2006，21(12):869-870.
|
| 27 |
Rand T, Loewe C, Schoder M, et al. Arterial embolization of unresectable hepatocellular carcinoma with use of microspheres, lipiodol, and cyanoacrylate [J]. Cardiovasc Intervent Radiol, 2005,28(3):313-318.
|
| 28 |
罗剑钧，颜志平，王建华，等. 微球+碘化油联合栓塞与碘化油单独栓塞治疗肝癌的比较研究[J].中国计算机成像杂志,2008,14(2):154-159.
|
| 29 |
陈红栓，白旭明，程龙，等.栓塞微球联合碘化油化疗栓塞治疗肝癌的临床研究[J].实用医学影像杂志，2012，13(4):266-269.
|
| 30 |
杨积慧，颜志平，王建华，等．ContourSe微球联合碘油栓塞治疗大肝癌的初步临床研究[J].中国临床医学,2008,15(6):798-801．
|
| 31 |
杨建东，孔曼，黄希芬，等.应用海藻酸钠微球联合碘化油经导管肝动脉化疗栓塞治疗肝癌[J].中国介入影像与治疗学，2010,7(3):225-227.
|
| 32 |
Yamasaki T, Hamabe S, Saeki I, et al. A novel transcatheter arterial infusion chemotherapy using iodized oil and degradable starch microspheres for hepatocellular carcinoma: a prospective randomized trial[J]. J Gastroenterol. 2011,46(3):359-366.
|